In vitro biotransformation of imatinib by the tumor expressed CYP1A1 and CYP1B1

Biopharmaceutics & Drug Disposition
Bertrand RochatOlivier Michielin

Abstract

The main objective of the study was to examine the biotransformation of the anticancer drug imatinib in target cells by incubating it with oxidoreductases expressed in tumor cells. The second objective was to obtain an in silico prediction of the potential activity of imatinib metabolites. An in vitro enzyme kinetic study was performed with cDNA expressed human oxidoreductases and LC-MS/MS analysis. The kinetic parameters (Km and Vmax) were determined for six metabolites. A molecular modeling approach was used to dock these metabolites to the target Abl or Bcr-Abl kinases. CYP3A4 isozyme showed the broadest metabolic capacity, whereas CYP1A1, CYP1B1 and FMO3 isozymes biotransformed imatinib with a high intrinsic clearance. The predicted binding modes for the metabolites to Abl were comparable to that of the parent drug, suggesting potential activity. These findings indicate that CYP1A1 and CYP1B1, which are known to be overexpressed in a wide range of tumors, are involved in the biotransformation of imatinib. They could play a role in imatinib disposition in the targeted stem, progenitor and differentiated cancer cells, with a possible contribution of the metabolites toward the activity of the drug.

References

May 25, 1977·Journal of Molecular Biology·F C BernsteinM Tasumi
Jun 22, 2000·Pharmacology & Toxicology·M SpatzeneggerR K Verbeeck
Dec 26, 2001·The Journal of Pharmacology and Experimental Therapeutics·Takanori HashizumeYoshihiko Funae
Jan 5, 2002·International Journal of Cancer. Journal International Du Cancer·Yasuo MiyoshiShinzaburo Noguchi
Mar 27, 2002·Biological & Pharmaceutical Bulletin·Fusako NagaiHiro-Omi Tamura
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Yasushi KikutaMasamichi Kusunose
Jun 28, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hassan R DhainiLaurence H Baker
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lee Anne McLeanMarlene Dressman
Jan 28, 2004·Cancer Research·Nicholas J DonatoShishir Shishodin
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marlene A DressmanUNKNOWN International Randomized Study of Interferon-alpha versus ST1571 Study Group
Apr 23, 2004·Leukemia & Lymphoma·Melissa S Holtz, Ravi Bhatia
Apr 28, 2004·Leukemia Research·Heiko van der KuipWalter E Aulitzky
May 18, 2004·Journal of Lipid Research·Valérie Le QuéréJean-Pierre Salaün
Jun 8, 2004·Current Drug Metabolism·Jose A G Agundez
Jun 16, 2004·Cancer Biology & Therapy·Hans Peter Rutz, Ingrid Herr
Jul 9, 2004·Biochimica Et Biophysica Acta·Yasushi KikutaKiyofumi Nakata
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Nov 6, 2004·Blood·Lucy J ElrickTessa L Holyoake
Nov 24, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Peng WangLin Fang
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Michael, M M Doherty
Jun 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cristina R AntonescuRonald P DeMatteo
Jun 30, 2005·Cancer Causes & Control : CCC·Jill Everland LarsenKwun Meng Fong
Jul 1, 2005·Nature·Franziska MichorMartin A Nowak
Jul 12, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hans-Peter GschwindGerhard Gross
Jul 22, 2005·Blood·Lucy C CrossmanRichard E Clark
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Angela DeMicheleTimothy R Rebbeck

❮ Previous
Next ❯

Citations

Mar 23, 2011·Drug Metabolism and Pharmacokinetics·Yoshiyuki YamauraYasushi Yamazoe
Jul 15, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Muhammad Suleman KhanAndrew A Somogyi
Jan 2, 2016·Pharmacological Reviews·Janne T BackmanPertti J Neuvonen
Sep 8, 2009·Cancer Treatment Reviews·Nielka P van ErpHenk-Jan Guchelaar
May 5, 2011·Journal of Computational Chemistry·Aurélien GrosdidierOlivier Michielin
Sep 19, 2017·Journal of Clinical Pharmacology·Catherine J Lucas, Jennifer H Martin
Oct 3, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Anne M FilppulaJanne T Backman
Dec 21, 2016·Clinical Pharmacokinetics·Daniel T BarrattAndrew A Somogyi
Mar 27, 2021·Journal of Biomolecular Structure & Dynamics·Baddipadige RajuOm Silakari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.